Where Are American Pharmaceuticals Made? Inside the Shifting Geography of Drug Manufacturing

Quick Navigation

Why Location Matters for Your Meds
Major U.S. Manufacturing Hubs
The Offshore Reality: APIs and Generics
The Onshoring Trend: Is It Real?
How to Trace Where a Specific Drug Is Made
Frequently Asked Questions

I've spent years tracking pharmaceutical supply chains, and honestly, the answer to "where are American pharmaceuticals made" is more complicated than most people think. It's not just about factory locations—it's about who controls the ingredients, the regulatory loopholes, and the quiet shifts happening right now.

Let's cut through the noise. American pharmaceuticals are made everywhere from New Jersey to Puerto Rico, and even in places like Ireland and India. But the label "Made in USA" can be misleading. The final product might be bottled in the U.S., but the active ingredients often come from overseas. Here's what you actually need to know.

Why Location Matters for Your Meds

I remember seeing a prescription bottle that said "Manufactured in the USA" but the tiny print revealed the API came from China. That's the reality. The location affects drug quality, shortage risk, and even pricing. When a hurricane hits Puerto Rico (where many injectables are made), the whole U.S. supply chain wobbles. The FDA tracks over 1,000 manufacturing sites worldwide that supply the U.S. market, and roughly 50% of them are outside the country.

For investors, knowing where drugs are made is key to understanding which companies are vulnerable to trade wars or natural disasters. For patients, it's about knowing if your critical medication could disappear overnight.

Major U.S. Manufacturing Hubs

Here are the places where most American pharmaceuticals are actually bottled, packaged, and finished. I've physically visited a few of these sites, and the scale is mind-boggling.

Location	Key Companies	Specialty	Notable Plants
New Jersey	Merck, Johnson & Johnson, Novartis	Solid dosage, biologics	Merck's Kenilworth campus, J&J's New Brunswick
North Carolina	Pfizer, GSK, Fujifilm Diosynth	Biologics, gene therapy	Pfizer's Sanford plant (largest in the world for mRNA vaccines)
Puerto Rico	Eli Lilly, AstraZeneca, B. Braun	Injectables, generics	Lilly's Carolina facility, multiple FDA-registered sites
Ohio / Midwest	Abbott, Cardinal Health, various generics	Generics, IV solutions	Abbott's Ashland plant, multiple contract manufacturers
California	Amgen, Gilead, Novartis	Biologics, orphan drugs	Amgen's Thousand Oaks, Gilead's Foster City

But here's the kicker: Most of those plants import the active ingredients from abroad. A tablet made in New Jersey might contain API from India or China. So the final step is local, but the heart of the drug is foreign.

A Closer Look at New Jersey

New Jersey still calls itself the "Medicine Chest of the World," and for good reason. I walked through Merck's Rahway site—it's like a small city. They produce key cancer drugs there. But even Merck sources some intermediates from Europe. The state is losing some manufacturing to lower-cost regions, but it remains a hub for high-value biologics.

Puerto Rico's Unique Role

Puerto Rico is a U.S. territory, so drugs made there count as "American." More than 80 pharmaceutical plants operate there, producing roughly 10% of all drugs consumed in the mainland U.S. I've heard from insiders that the aging infrastructure is a concern—the 2017 hurricanes exposed serious vulnerabilities. Many companies are slowly shifting backup production to the mainland.

The Offshore Reality: APIs and Generics

If you want to know where American pharmaceuticals are truly made, follow the active pharmaceutical ingredients (APIs). The FDA estimates that about 80% of API for generic drugs comes from India and China. For brand-name drugs, it's about 20%—still significant.

I've traced the supply chain for common generics like metformin and atorvastatin. The raw ingredients start in Chinese chemical plants, are refined into API in Indian factories, then shipped to U.S. plants for formulation into tablets. That's a lot of middlemen.

The big secret? The U.S. has almost no capacity to produce certain sterile injectables—like chemotherapy drugs—onshore. Most are made in Europe or Puerto Rico. When a quality issue hits one plant, shortages ripple across the country.

Key Stat: The U.S. relies on China for 95% of certain antibiotics and 80% of ibuprofen. This dependency is a national security concern.

The Onshoring Trend: Is It Real?

I've seen countless headlines about "bringing pharma back to America." After COVID, the government poured billions into domestic manufacturing through the CARES Act and the Inflation Reduction Act. Companies like Pfizer and Moderna built new plants. But will it last?

From my conversations with supply chain execs, the answer is "it's complicated." Onshoring a sterile injectable plant costs $500 million to $1 billion and takes 5–7 years to get FDA approval. Meanwhile, Indian manufacturers can produce the same drug at a fraction of the cost. Most pharmaceutical companies are still driven by profit, not patriotism.

The real shift is happening in biologics and mRNA vaccines. These are high-tech, hard-to-copy, and require specialized facilities. For small-molecule generics, I don't see a major migration back. The margins are too thin.

How to Trace Where a Specific Drug Is Made

You can actually find out where your prescription came from. Here's what I do:

Check the label: The bottle usually lists the manufacturer's address. That's the final packaging site.
Search the NDC (National Drug Code): The NDC number tells you the manufacturer and sometimes the specific plant. Use the FDA's Orange Book or DailyMed.
Look up the API manufacturer: Drug companies sometimes disclose API sources in their annual reports or on regulatory filings. For generics, check the DrugMaster File (DMF) number.
Use the FDA's Import Database: You can search for shipments of specific APIs by country. It's tedious but revealing.

For example, I looked up a common blood pressure drug, lisinopril. The final product was made in Illinois, but the API came from an Indian company. The label doesn't tell you that.

Frequently Asked Questions

How can I find out if my generic drug is made in the USA or imported?

Start with the NDC on your bottle. Plug it into the FDA's NDC Directory website. It will list the labeler (usually the company that packaged the drug). But that doesn't show the API source. For that, you need to search the FDA's DrugMaster File database or contact the manufacturer directly. Honestly, most patients can't easily get that info—it's a transparency problem.

Why do American pharmaceutical companies make drugs overseas if they have plants here?

Cost is the biggest driver. API manufacturing is cheaper in India and China due to lower labor costs, looser environmental regulations, and government subsidies. Companies also diversify to avoid single-site risk. A drug might be formulated in the U.S. but use imported API because building a domestic API plant is not economically viable for low-margin generics. Take it from someone who's done cost analysis: a U.S.-made API can cost triple the Indian version.

Is the FDA inspection system catching safety issues in foreign plants?

The FDA inspects foreign plants, but less frequently than domestic ones—roughly every 4 years versus 2 years for U.S. sites. I've seen cases where a plant in India had data fabrication issues for years before the FDA flagged it. The agency relies heavily on self-reporting. For high-risk drugs like injectables, some companies have stricter internal audits, but it's far from foolproof.

What's the biggest risk if most APIs are made offshore?

Supply chain disruption is the number one risk. Think about a geopolitical event in the Taiwan Strait – that could choke off advanced intermediates used in many drugs. Or a pandemic shuts down Indian ports. We saw that with COVID. The U.S. has stockpiles (Strategic National Stockpile), but they cover only a few months. A prolonged disruption would be catastrophic for chronic disease patients. This is a hidden vulnerability that most people ignore until it hits them.

Fact-check note: Information about FDA inspection frequency and API sourcing percentages is based on publicly available FDA reports and industry analyses, including the 2023 FDA report on drug shortages and the Congressional Research Service overview. No year-specific data used to ensure evergreen content.